CompanyHealthHardware
Switch Therapeutics
Switch Therapeutics is a South San Francisco preclinical biotech building conditionally activated siRNA (CASi) therapies that only switch on inside the cell types where they're needed. The platform - born from research at Caltech, Harvard and City of Hope - aims to make RNA interference safe enough for the brain, with a lead program targeting APOE for Alzheimer's disease.
2020Founded
South San FranciscoHQ
~$23MEarlier Rounds
biotechrnaisirnacnsneurodegenerationalzheimers